181 related articles for article (PubMed ID: 4133325)
1. [Drug-induced liver damage following use of the oral contraceptive Femigen].
Kwaśniewska W; Raczyńska A
Patol Pol; 1974; 25(1):101-6. PubMed ID: 4133325
[No Abstract] [Full Text] [Related]
2. [Liver function and glucose tolerance during treatment with the oral contraceptive ovosiston].
Heller H
Dtsch Gesundheitsw; 1972 Jun; 27(22):1035-8. PubMed ID: 4114489
[No Abstract] [Full Text] [Related]
3. [Incidence of arterial hypertension in women taking oral hormonal contraceptive agents (femigen)].
Mikrut W
Wiad Lek; 1983 Oct; 36(19):1587-92. PubMed ID: 6198806
[TBL] [Abstract][Full Text] [Related]
4. [Cholestatic icterus after intake of ovulation inhibitors].
Pansold E; Fischer I; Pfeifer K
Dtsch Gesundheitsw; 1974 Mar; 29(10):470-5. PubMed ID: 4142434
[TBL] [Abstract][Full Text] [Related]
5. Jaundice and oral contraceptives.
Dooner HP; Hoyl C; Aliaga C; Parada J
Acta Hepatosplenol; 1971; 18(2):84-94. PubMed ID: 5552035
[No Abstract] [Full Text] [Related]
6. [Jaundice in intrahepatic cholestasis after ovulation inhibitors].
Piesbergen H
Med Welt; 1968 Feb; 9():451-3. PubMed ID: 4181421
[No Abstract] [Full Text] [Related]
7. [Femigen forte and mite preparations in contraception and gynecologival disorders].
Sternadel Z; Pietrusiewicz W; Wasilewska B
Ginekol Pol; 1970 Nov; 41(11):1227-36. PubMed ID: 4098877
[TBL] [Abstract][Full Text] [Related]
8. [Use of an oral contraceptive Femigen-Polfa by epileptic women].
Rościszewska D
Neurol Neurochir Pol; 1973; 7(5):715-7. PubMed ID: 4128492
[No Abstract] [Full Text] [Related]
9. [Porphyria cutanea tarda caused by long-term use of femigen].
Chowaniec O; Wierzbieta J
Przegl Dermatol; 1980; 67(3):349-52. PubMed ID: 6159665
[TBL] [Abstract][Full Text] [Related]
10. [Intrahepatic cholestasis in hormonal contraception--a case with a difficult and expensive differential diagnosis].
Böhme HH; Otto HJ
Zentralbl Gynakol; 1985; 107(5):311-2. PubMed ID: 2581395
[TBL] [Abstract][Full Text] [Related]
11. [Raynaud-like clinical picture during the treatment with an oral contraceptive].
Ebert H
Dtsch Gesundheitsw; 1970 Aug; 25(35):1642-3. PubMed ID: 4099005
[No Abstract] [Full Text] [Related]
12. [Disorders of the blood coagulation system and liver damage after using gestagen preparations].
Rusinowska Z; Hołowiecka B; Kardaszewicz S
Pol Tyg Lek; 1985 Jul; 40(30):848-9. PubMed ID: 2414762
[No Abstract] [Full Text] [Related]
13. [A case of jaundice due to oral contraceptives].
Dal Monte PR; Sarti F; Toscano S; Pasotto A
G Clin Med; 1972 Mar; 53(3):111-20. PubMed ID: 4649401
[No Abstract] [Full Text] [Related]
14. Some apparently common problems in patients receiving contraceptive pills.
Ball P
Nebr State Med J; 1968 Sep; 53(9):428-32. PubMed ID: 4176717
[No Abstract] [Full Text] [Related]
15. [Intrahepatic cholestasis following ovosiston].
Kraatz G; Linke A
Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1194-6. PubMed ID: 4135044
[No Abstract] [Full Text] [Related]
16. Psychosis associated with the use of a sequential oral contraceptive.
Daly RJ; Kane FJ; Ewing JA
Lancet; 1967 Aug; 2(7513):444-5. PubMed ID: 4166106
[No Abstract] [Full Text] [Related]
17. [Sequenz-Ovosiston as a contraceptive agent].
Zwahr C
Zentralbl Gynakol; 1972 Dec; 94(49):1722-5. PubMed ID: 4119508
[No Abstract] [Full Text] [Related]
18. [Effect of oral contraceptives and epsilon-aminocaproic acid on pregnant female rats and their fetuses. Histopathologic study].
Niznikowska-Marks MJ; Oknińska A; Gawlik Z; Grygalewicz J; Galczak W; Ostojska J
Patol Pol; 1981; 32(1):37-52. PubMed ID: 6171763
[No Abstract] [Full Text] [Related]
19. [Adverse effects of oral contraceptives].
Adam H; Schirmer B
Z Arztl Fortbild (Jena); 1973 Nov; 67(21):1078-81. PubMed ID: 4130135
[No Abstract] [Full Text] [Related]
20. [Menstruation disorders due to Ovosiston medication].
Kühndel K; Ebeling K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
